Search Results
Results found for "Montana Molecular"
- Pharmacology Isn't What You Think—It's So Much More
” Terry Kenakin explains why pharmacology isn’t a clean-cut science—it’s a dynamic dialogue between molecule
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
receptors are dense (like GPCRs on membranes), this rebinding hits the collisional limit , where every molecular
- GRK2 in cardiovascular disease and its potential as a therapeutic target
Thus, identifying novel molecular targets for developing HF therapeutics remains a key research focus
- Why Mastering Pharmacokinetics Fundamentals Still Defines Discovery Success Today
Solubility, lipophilicity (e.g., logP), and polarity govern whether molecules can cross membranes, dissolve Passive diffusion dominates for many small molecules, but protein binding, transporters, and tissue architecture design through population modeling— correlates with clinical success Scientists need to “think like a molecule
- How GPCR Spatial Signaling Sparked a Scientific Journey
From Cambridge to Leadership That early curiosity led her to pursue a PhD in Molecular Pharmacology at
- A Chemical Biology Toolbox Targeting the Intracellular Binding Site of CCR9: Fluorescent Ligands ...
Applying this molecular tool in a membrane-based setup and in living cells, we discovered a 4-aminopyrimidine
- Dynamic recognition of naloxone, morphine and endomorphin1 in the same pocket of µ-opioid receptors
Molecular dynamics (MD) simulations on a 1-μs time scale and metadynamics-enhanced conformational sampling
- Canonical chemokine receptors as scavenging “decoys”
receptor that directly regulates both cell migration and scavenging (Volpe S. et al., 2012), which molecular
- G protein-coupled receptors that influence lifespan of human and animal models
affect the lifespan of animal and human models, and in which we put a special interest in describing the molecular
- Genome-scale CRISPR screening reveals that C3aR signaling is critical for rapid capture of fungi...
To interrogate the molecular mechanisms underlying this interaction, we conducted a host-directed CRISPR-Cas9
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
In the realm of molecular research, precise interpretation is crucial; a misread curve can lead to lost
- Integrated GPCR Drug Discovery: A Structured Framework for Modern Programs
As AlphaFold and molecular dynamics simulations accelerate hypothesis generation, disciplined experimental
- Biased GPCR signaling by the native parathyroid hormone-related protein 1 to 141 relative to its...
Furthermore, we show that the molecular basis for biased signaling differences between PTHrP1-36 and
- GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to...
However, its biological function and underlying molecular mechanism in breast cancer have not been clearly
- Phospholipid Scrambling by G Protein-Coupled Receptors
Atomistic molecular dynamics simulations of opsin in a lipid membrane reveal conformational transitions
- 📰 GPCR Weekly News, June 10 to 16, 2024
therapeutics in targeting G protein-coupled receptors: Recent advances and challenges Structural and Molecular
- Ever Wondered How Drugs Are Discovered?
How do molecules make the leap from laboratory concept to therapeutic reality?
- A new Kunitz-type snake toxin family associated with an original mode of interaction with the...
to exploit other mamba venoms to enlarge the V2R-Kunitz peptide family and gain insight into the MQ1 molecular
- 📢 GPCR Update: August 19-25, 2024 | Thrilling Announcement: New Pharmacology Course Dates & Exclusive Discounts Inside!
Candidate NBI-1117568 Call for GPCR Papers NEW Emerging Voices in GPCR Biology in Special Issue of Molecular
- How Schild Analysis Protects Your Conclusions in GPCR Research
to Platforms: The Evolution of GPCR Research How GPCR Spatial Signaling Sparked a Scientific Journey Molecular
- Functional Characterization of the Venus Flytrap Domain of the Human TAS1R2 Sweet Taste Receptor
However, cellular assays, molecular docking and site-directed mutagenesis studies have revealed that
- GPCR/endocytosis/ERK signaling/S2R is involved in the regulation of the internalization...
that fluorescently labeled Hst1 (F-Hst1) targets and activates mitochondria, presenting an important molecular
- Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline ...
from target identification through patient selection Research will be focused on up to 15 novel small molecule today a groundbreaking research collaboration and license agreement to develop up to 15 novel small molecule been working together since 2016 and in 2019, Sanofi in-licensed Exscientia’s novel bispecific small molecule
- Novel interaction between neurotrophic factor-α1/carboxypeptidase E and serotonin receptor, 5-HTR1E,
Molecular dynamics studies revealed that NF-α1/CPE interacts with 5-HTR1E via 3 salt bridges, stabilized
- In Vitro and In Silico Characterization of Kurarinone as a Dopamine D 1A Receptor Antagonist and ...
Molecular docking displayed low binding energies during the intermolecular interactions of kurarinone
- Chemogenetic stimulation of the G i pathway in astrocytes suppresses neuroinflammation
an inhibitory role in neuroinflammation, providing an opportunity to identify potential cellular and molecular
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
If you work on GPCRs across translational pharmacology, drug development, or molecular pharmacology,
- Design Pharmaceuticals Closes $5 Million Pre-series A Round to Accelerate Commercialization of ...
--Design Pharmaceuticals, a company redesigning small molecule drug discovery, today announced the closing Design Pharmaceuticals’ platform is based on ultrahigh-throughput technologies that biomine drug-like molecules These molecules are then evaluated at unprecedented speed and scale on hundreds of GPCR targets simultaneously
- Science Needs Rigor, But Also Joy
But every day also includes squirrel-themed trivia and impromptu debates about obscure molecules.
- Platelets in the NETworks interweaving inflammation and thrombosis
A better understanding of the underlying molecular mechanisms and the identification of treatment targets











